Original document(96 pages)  中文版
    Compounds of formula I, processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders and to pharmaceutical compositions containing them.
Application Number
申请号		 200580009157 Application Date
申请日		 2005.03.21
Title 名称 N-piperidine derivates as CCR3 modulators
Publication Number
公开号		 1934099 Publication Date
公开日		 2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D401/12;C07D413/12;C07D417/12;A61K31/454;A61K31/445;A61P3/04;A61P25/00
Applicant(s) Name
申请人		 Astrazeneca AB
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 zoufeng lilian tao
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.